Additional treatment is with sodium benzoate, phenylbutyrate, or phenylacetate, which by conjugating glycine (sodium benzoate) and glutamine (phenylbutyrate and phenylacetate) provides a "nitrogen sink." Despite these therapeutic advances, many UCDs remain difficult to treat, and liver transplantation is eventually required for many patients.